Kestra Medical Technologies, Ltd.
KMTS
$20.70
$1.115.67%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -144.83M | -132.17M | -119.76M | -113.81M | -84.05M |
| Total Depreciation and Amortization | 8.22M | 8.13M | 7.62M | 7.97M | 9.63M |
| Total Amortization of Deferred Charges | 1.78M | 1.48M | 1.67M | 1.40M | 1.23M |
| Total Other Non-Cash Items | 54.77M | 45.35M | 36.86M | 35.07M | 6.89M |
| Change in Net Operating Assets | -6.61M | -9.09M | -12.42M | -7.88M | -2.21M |
| Cash from Operations | -86.68M | -86.31M | -86.03M | -77.25M | -68.50M |
| Capital Expenditure | -33.80M | -28.31M | -25.43M | -24.22M | -20.38M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.53M | 443.00K | 567.00K | 553.00K | 312.00K |
| Cash from Investing | -38.33M | -27.86M | -24.86M | -23.67M | -20.06M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 367.45M | 218.16M | 218.16M | 218.16M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 0.00 | 103.40M | 115.90M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.47M | -5.48M | -6.03M | 8.70M | 11.90M |
| Cash from Financing | 361.98M | 212.68M | 212.13M | 330.26M | 127.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 236.97M | 98.51M | 101.25M | 229.35M | 39.23M |